MedPath

Effects of Exercise on Fructose Metabolism

Not Applicable
Completed
Conditions
Healthy Subjects
Interventions
Other: exercise
Dietary Supplement: fructose
Dietary Supplement: glucose
Registration Number
NCT01866215
Lead Sponsor
University of Lausanne
Brief Summary

A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced dyslipidemia.This study will evaluate

1. how exercise effects the metabolic fate of oral fructose 1a) when exercise is performed before fructose ingestion 1b) when exercise is performed after fructose ingestion Metabolic effects of exercise will be assessed in healthy male subjects by measuring fructose oxidation (13CO2 production), fructose conversion into glucose (13C glucose concentrations in blood) and hepatic fructose conversion into lipid (13C palmitate-very low density lipoprotein (VLDL) concentrations in blood) after ingestion of 13C-labelled fructose meals

2. how fructose and protein modulate muscle glycogen and intramyocellular lipid repletion after exercise Healthy male subjects will be fed various fructose, glucose, lipid and whey protein meals after a glycogen/intramyocellular lipid depleting exercise. The effects of meals' composition will be assessed after 24 hours by measuring intramyocellular lipids and glycogen using proton-magnetic resonance spectroscopy (MRS).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
8
Inclusion Criteria
  • males
  • 18-40 years old
  • 19 kg/m2>BMI>25kg/m2
  • moderate to high usual physical activity
  • non-smokers
Exclusion Criteria
  • family history of diabetes mellitus
  • ECG anomaly
  • any medication
  • participation to blood spending or other clinical study in the 3 months before the beginning of this study
  • consumption of drugs
  • consumption of more than 50g alcool/week
  • family history of food intolerance

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Study1aexerciseexercice performed 90 min before 13C fructose meal ingestion
study 1bexerciseexercise performed 90 min after 13C fructose meal ingestion
study 2afructosemeals containing fructose, cream and whey proteins over 24 hours after a glycogen/intramyocellular lipid depleting exercise
study 2bglucosemeals containing glucose, cream and whey proteins over 24 hours after a glycogen/intramyocellular lipid depleting exercise
Primary Outcome Measures
NameTimeMethod
Plasma triglyceridemeasurements in fasting conditions and every hour from 7:00 am to 4:00 pm (up to 9 hours)

measurement of total and VLDL-TG concentrations in study 1

intramyocellular lipidsafter glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise

Measurement by 1H-MRS in muscle vastus lateralis in study 2

Fructose conversion into lipidsmeasured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)

Estimated from 13C palmitate-VLDL concentration

Secondary Outcome Measures
NameTimeMethod
Fructose conversion into glucosemeasured between 7:00 am and 4:oo pm (up to 9 hours)

measurements obtained from plasma 13C glucose concentrations and whole body glucose production measured by 6,6 d2 glucose in study 1)

intramyocellular glycogen concentrationsafter glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise

Measured by 1H-MRS in muscle vastus lateralis in study 2

fructose oxidationmeasured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)

Calculated from breath 13CO2 production

exogenous lipid oxidationmeasured from 7:00 am to 4:00 pm in study 2 (up to 9 hours)

Lipids ingested will be labeled with 13C-triolein, and exogenous lipid oxidation will be measured from breath 13CO2 production

Trial Locations

Locations (1)

Centre Hospitalier Universitaire Vaudois

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath